United Orthopedic Corporation (TPEX:4129)

Market Cap	10.17B
Revenue (ttm)	4.88B
Net Income (ttm)	553.05M
Shares Out	96.44M
EPS (ttm)	5.74
PE Ratio	18.39
Forward PE	n/a
Dividend	4.00 (3.77%)
Ex-Dividend Date	Jul 23, 2025

Volume	644,772
Average Volume	250,495
Open	106.00
Previous Close	105.50
Day's Range	104.50 - 106.50
52-Week Range	77.30 - 112.00
Beta	0.44
RSI	54.51
Earnings Date	Aug 12, 2025

About United Orthopedic

United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine produ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1993
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4129

Financial Performance

In 2024, United Orthopedic's revenue was 4.65 billion, an increase of 18.40% compared to the previous year's 3.93 billion. Earnings were 455.96 million, an increase of 20.11%.